Citius Oncology (CTOR) EBT (2023 - 2026)

Citius Oncology's EBT history runs 4 years deep, the most recent figure standing at -$26.8 million for Q1 2026.

• In Q1 2026, EBT fell 259.25% year-over-year to -$26.8 million; the TTM figure through Mar 2026 stood at -$41.9 million (down 80.92% YoY), while the FY2025 annual figure was -$23.7 million, down 15.22% from the prior year.
• EBT was -$26.8 million for Q1 2026 at Citius Oncology, down from -$5.3 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$147922.0 in Q1 2023 to a low of -$26.8 million in Q1 2026.
• Historically, EBT has averaged -$5.9 million across 4 years, with a median of -$4.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: EBT plunged 3071.64% in 2024, then advanced 17.59% in 2025.
• A 4-year view of EBT shows it stood at -$4.6 million in 2023, then tumbled by 39.52% to -$6.4 million in 2024, then rose by 17.59% to -$5.3 million in 2025, then sank by 409.33% to -$26.8 million in 2026.
• The last three EBT figures came in at -$26.8 million (Q1 2026), -$5.3 million (Q4 2025), and -$4.7 million (Q3 2025), per Business Quant data.